BARGAGLI ELENA

Teaching activities

Completion accademic year: 2021/2022

Course year: 2 Second cycle degree (Laurea Magistrale) HEALTH PROFESSIONS OF REHABILITATION SCIENCES A.Y. 2020/2021
Course year: 2 First cycle degree (DM 270) CARDIOCIRCULATORY AND CARDIOVASCULAR PERFUSION TECHNIQUES A.Y. 2020/2021
Course year: 1 First cycle degree (DM 270) ENVIRONMENT AND WORKPLACE PREVENTION TECHNIQUES A.Y. 2021/2022
Course year: 5 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2017/2018
Course year: 5 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2017/2018

Completion accademic year: 2020/2021

Course year: 2 First cycle degree (DM 270) CARDIOCIRCULATORY AND CARDIOVASCULAR PERFUSION TECHNIQUES A.Y. 2019/2020
Course year: 5 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2016/2017
Course year: 5 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2016/2017

Research

Ultime pubblicazioni:

  • D'alessandro, M., Bergantini, L., Torricelli, E., Cameli, P., Lavorini, F., Pieroni, M., et al. (2021). Systematic review and metanalysis of oncomarkers in ipf patients and serial changes of oncomarkers in a prospective italian real-life case series. CANCERS, 13(3), 1-14 [10.3390/cancers13030539]. - view more
  • d'Alessandro, M., Bergantini, L., Cameli, P., Curatola, G., Remediani, L., Sestini, P., et al. (2021). Peripheral biomarkers' panel for severe COVID-19 patients. JOURNAL OF MEDICAL VIROLOGY, 93(3), 1230-1232 [10.1002/jmv.26577]. - view more
  • d'Alessandro, M., Bergantini, L., Cameli, P., Curatola, G., Remediani, L., Bennett, D., et al. (2021). Serial KL-6 measurements in COVID-19 patients. INTERNAL AND EMERGENCY MEDICINE. - view more
  • Bergantini, L., d'Alessandro, M., Cameli, P., Bono, C., Perruzza, M., Biagini, M., et al. (2021). Regulatory T cell monitoring in severe eosinophilic asthma patients treated with mepolizumab. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, e13031 [10.1111/sji.13031]. - view more
  • d'Alessandro, M., Bergantini, L., Cameli, P., Pieroni, M., Refini, R.M., Sestini, P., et al. (2021). Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy. CANCERS, 13(4), 689 [10.3390/cancers13040689]. - view more